Back to
Osaic Holdings, Inc.
CLDX
26 quarters
Position history for
Osaic Holdings, Inc.'s holdings in Celldex Therapeutics, Inc.
Yes. Osaic holds 862 shares of CLDX (Celldex Therapeutics), worth $32,067, as of its Q2 2026 13F filing. It reduced the position by 90 shares (-9.5%) from Q1 2026. Osaic has held CLDX in every 13F on record since Q1 2020, 26 quarterly filings.
Current Value
$32,067
Current Shares
862
Total Value Change
+$31,067
Total Shares Change
-92
Quarter-by-Quarter History
Other major holders of CLDX: FMR LLC, Wellington Management Group LLP